Chemoinformaics analysis of (-)-BORNYL-FERULATE
| Molecular Weight | 330.424 | nRot | 4 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 16 |
| Exact Molecular Weight | 330.183 | nRing | 3 |
| Solubility: LogS | -5.056 | nHRing | 0 |
| Solubility: LogP | 4.349 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 53.9446 |
| nHD | 1 | BPOL | 30.4234 |
| QED | 0.665 |
| Synth | 4.099 |
| Natural Product Likeliness | 1.759 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.931 |
| Pgp-sub | 0.007 |
| HIA | 0.006 |
| CACO-2 | -4.734 |
| MDCK | 0.000022 |
| BBB | 0.164 |
| PPB | 0.987733 |
| VDSS | 2.116 |
| FU | 0.0219264 |
| CYP1A2-inh | 0.368 |
| CYP1A2-sub | 0.905 |
| CYP2c19-inh | 0.694 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.501 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.36 |
| CYP2d6-sub | 0.912 |
| CYP3a4-inh | 0.611 |
| CYP3a4-sub | 0.316 |
| CL | 12.243 |
| T12 | 0.388 |
| hERG | 0.148 |
| Ames | 0.011 |
| ROA | 0.076 |
| SkinSen | 0.95 |
| Carcinogencity | 0.109 |
| EI | 0.429 |
| Respiratory | 0.935 |
| NR-Aromatase | 0.802 |
| Antiviral | Yes |
| Prediction | 0.681861 |